Eintrag weiter verarbeiten
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study
Gespeichert in:
Zeitschriftentitel: | BioMed Research International |
---|---|
Personen und Körperschaften: | , , , , , , |
In: | BioMed Research International, 2016, 2016, S. 1-6 |
Medientyp: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Hindawi Limited
|
Schlagwörter: |
author_facet |
Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela |
---|---|
author |
Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela |
spellingShingle |
Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela BioMed Research International Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine |
author_sort |
loibl, markus |
spelling |
Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela 2314-6133 2314-6141 Hindawi Limited General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1155/2016/9262909 <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p> Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study BioMed Research International |
doi_str_mv |
10.1155/2016/9262909 |
facet_avail |
Online Free |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE2LzkyNjI5MDk |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE2LzkyNjI5MDk |
institution |
DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 |
imprint |
Hindawi Limited, 2016 |
imprint_str_mv |
Hindawi Limited, 2016 |
issn |
2314-6133 2314-6141 |
issn_str_mv |
2314-6133 2314-6141 |
language |
English |
mega_collection |
Hindawi Limited (CrossRef) |
match_str |
loibl2016leukocytereducedplateletrichplasmatreatmentofbasalthumbarthritisapilotstudy |
publishDateSort |
2016 |
publisher |
Hindawi Limited |
recordtype |
ai |
record_format |
ai |
series |
BioMed Research International |
source_id |
49 |
title |
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_unstemmed |
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_full |
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_fullStr |
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_full_unstemmed |
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_short |
Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_sort |
leukocyte-reduced platelet-rich plasma treatment of basal thumb arthritis: a pilot study |
topic |
General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine |
url |
http://dx.doi.org/10.1155/2016/9262909 |
publishDate |
2016 |
physical |
1-6 |
description |
<jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p> |
container_start_page |
1 |
container_title |
BioMed Research International |
container_volume |
2016 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792341401002835972 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:19:19.087Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Leukocyte-Reduced+Platelet-Rich+Plasma+Treatment+of+Basal+Thumb+Arthritis%3A+A+Pilot+Study&rft.date=2016-01-01&genre=article&issn=2314-6141&volume=2016&spage=1&epage=6&pages=1-6&jtitle=BioMed+Research+International&atitle=Leukocyte-Reduced+Platelet-Rich+Plasma+Treatment+of+Basal+Thumb+Arthritis%3A+A+Pilot+Study&aulast=Huber&aufirst=Michaela&rft_id=info%3Adoi%2F10.1155%2F2016%2F9262909&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792341401002835972 |
author | Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela |
author_facet | Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela, Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela |
author_sort | loibl, markus |
container_start_page | 1 |
container_title | BioMed Research International |
container_volume | 2016 |
description | <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p> |
doi_str_mv | 10.1155/2016/9262909 |
facet_avail | Online, Free |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE2LzkyNjI5MDk |
imprint | Hindawi Limited, 2016 |
imprint_str_mv | Hindawi Limited, 2016 |
institution | DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14 |
issn | 2314-6133, 2314-6141 |
issn_str_mv | 2314-6133, 2314-6141 |
language | English |
last_indexed | 2024-03-01T16:19:19.087Z |
match_str | loibl2016leukocytereducedplateletrichplasmatreatmentofbasalthumbarthritisapilotstudy |
mega_collection | Hindawi Limited (CrossRef) |
physical | 1-6 |
publishDate | 2016 |
publishDateSort | 2016 |
publisher | Hindawi Limited |
record_format | ai |
recordtype | ai |
series | BioMed Research International |
source_id | 49 |
spelling | Loibl, Markus Lang, Siegmund Dendl, Lena-Marie Nerlich, Michael Angele, Peter Gehmert, Sebastian Huber, Michaela 2314-6133 2314-6141 Hindawi Limited General Immunology and Microbiology General Biochemistry, Genetics and Molecular Biology General Medicine http://dx.doi.org/10.1155/2016/9262909 <jats:p>A positive effect of intra-articular platelet-rich plasma (PRP) injection has been discussed for osteoarthritic joint conditions in the last years. The purpose of this study was to evaluate PRP injection into the trapeziometacarpal (TMC) joint. We report about ten patients with TMC joint osteoarthritis (OA) that were treated with 2 intra-articular PRP injections 4 weeks apart. PRP was produced using the Double Syringe System (Arthrex Inc., Naples, Florida, USA). A total volume of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn fontstyle="italic">1.47</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.25</mml:mn></mml:math> mL PRP was injected at the first injection and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">1.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">0.41</mml:mn></mml:math> mL at the second injection, depending on the volume capacity of the joint. Patients were evaluated using VAS, strength measures, and the Mayo Wrist score and DASH score after 3 and 6 months. VAS significantly decreased from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn fontstyle="italic">6.2</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn fontstyle="italic">5.4</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.2</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). The DASH score was unaffected; however, the Mayo Wrist score significantly improved from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn fontstyle="italic">46.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">18.6</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn fontstyle="italic">67.5</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">19.0</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). Grip was unaffected, whereas pinch declined from<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn fontstyle="italic">6.02</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">2.99</mml:mn></mml:math>to<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mn fontstyle="italic">3.96</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">1.77</mml:mn></mml:math>at six-month follow-up (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn fontstyle="italic">0</mml:mn><mml:mo>.</mml:mo><mml:mn fontstyle="italic">05</mml:mn></mml:math>). We did not observe adverse events after the injection of PRP, except one occurrence of a palmar wrist ganglion, which resolved without treatment. PRP injection for symptomatic TMC OA is a reasonable therapeutic option in early stages TMC OA and can be performed with little to no morbidity.</jats:p> Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study BioMed Research International |
spellingShingle | Loibl, Markus, Lang, Siegmund, Dendl, Lena-Marie, Nerlich, Michael, Angele, Peter, Gehmert, Sebastian, Huber, Michaela, BioMed Research International, Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study, General Immunology and Microbiology, General Biochemistry, Genetics and Molecular Biology, General Medicine |
title | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_full | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_fullStr | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_full_unstemmed | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_short | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
title_sort | leukocyte-reduced platelet-rich plasma treatment of basal thumb arthritis: a pilot study |
title_unstemmed | Leukocyte-Reduced Platelet-Rich Plasma Treatment of Basal Thumb Arthritis: A Pilot Study |
topic | General Immunology and Microbiology, General Biochemistry, Genetics and Molecular Biology, General Medicine |
url | http://dx.doi.org/10.1155/2016/9262909 |